Epoprostenol discontinuation in patients with pulmonary arterial hypertension: a complex medical and social problem
Pulm Circ
.
2018 Jan-Mar;8(1):2045893217753352.
doi: 10.1177/2045893217753352.
Epub 2017 Dec 28.
Authors
Nader Chebib
1
,
Vincent Cottin
1
2
,
Martine Taharo-Ag-Ralissoum
1
,
Michel Chuzeville
3
,
Jean-François Mornex
1
2
Affiliations
1
1 Hospices Civils de Lyon, National Reference Center for Rare Pulmonary Diseases, Competence Center for Pulmonary Hypertension, Lyon, France.
2
2 Claude Bernard Lyon 1 University, University of Lyon, Lyon, France.
3
3 Hospices Civils de Lyon, Hôpital Edouard Herriot, Cardiogeriatrics Department, Lyon, France.
PMID:
29283031
PMCID:
PMC6022074
DOI:
10.1177/2045893217753352
No abstract available